Validation of a point of care lipid analyser using a hospital based reference laboratory

被引:75
作者
Carey, M.
Markham, C.
Gaffney, P.
Boran, G.
Maher, V. [1 ]
机构
[1] Adelaide Meath Hosp, Dept Cardiol, Dublin 24, Ireland
[2] Adelaide Meath Hosp, Dept Chem Pathol, Dublin 24, Ireland
[3] Natl Childrens Hosp, Dublin, Ireland
关键词
High Density Lipoprotein Cholesterol; IRISH Journal; Venous Sample; Lipid Measurement; Finger Prick;
D O I
10.1007/BF03167964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lipid measurements are essential in cardiovascular disease management in primary care. However, utilizing hospital laboratories may result in excess patient travel, sample loss and repeat clinic visits. Point of care (POC) lipid measurement would overcome these difficulties but has not been validated in an Irish setting. Aim To compare POC lipid profile measurements using a cholestech LDX analyser with a hospital reference laboratory (Lab). Method One-hundred subjects (30 men,70 women) participated. Finger prick and venous samples were analysed directly by Cholestech LDX and the Lab. Results A broad range of lipid values were measured. Absolute differences between POC and Lab measurements were insignificant except for a small over-estimation by the POC method of triglyceride 0.25 mmol/l (95% CI 0.17 to 0.24), and an underestimation of HDLc - 0.11 mmol/l (95% CI -0.143 to -0.078). There were significant correlations between POC and Lab. levels; total cholesterol r = 0.92, triglyceride r = 0.93, HDLc r = 0.92 and LDLc r = 0.86 (all p < 0.0001). Conclusion These results validate the use of the Cholestech LDX(R) analyser for point of care lipid measurements in clinical practice, provided well trained operators are supported by a hospital laboratory delivering quality assurance support.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 10 条
[1]  
*AC MED LAB SCI, 1998, POL GUID NEAR PAT TE
[2]  
Cummings MH, 1994, PRACTICAL DIABETES, V11, P151
[3]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]  
*GUINN CTR, POINT CAR DIAGN TEST
[6]  
*ICGP, HEARTW NAT PROGR GEN
[7]  
*IS HEART FDN, 2001, 50 YEARS HEART DIS I
[8]   Additional Essential Criteria for Quality Systems of Medical Laboratories [J].
Jansen, RTP ;
Blaton, V ;
Burnett, D ;
Huisman, W ;
Queralto, JM ;
Zerah, S ;
Allman, B .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (04) :249-252
[9]  
SLOOP CH, 1987, J LIPID RES, V28, P225
[10]  
*UK JOINT WORK GRO, 1999, NEAR PAT POINT CAR T